Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis
1. Use of Sodium-Glucose Cotransporter 2 (SGLT-2) inhibitors among adults with cirrhosis receiving diuretic therapy was associated with lower incidence ...